 "Lupin appoints Jim Loerop to drive M&A, business development strategy")
Lupin has appointed Jim Loerop, a senior pharmaceutical industry executive, to drive its mergers, acquisitions and business development strategy. Loerop will hold the position of chief corporate development officer.
His appointment comes at a time when the Indian drug maker is scouting for speciality assets in women's health and neurology segments in the United States and other regulated markets. Prior to joining Lupin, Loerop served as senior vice-president in Alexion Pharmaceuticals and looked after global business development.
His appointment comes at a time when the Indian drug maker is scouting for speciality assets in women's health and neurology segments in the United States and other regulated markets. Prior to joining Lupin, Loerop served as senior vice-president in Alexion Pharmaceuticals and looked after global business development.
In a statement, Lupin's Chief Executive Officer Vinita Gupta said, “Jim's rich experience in both branded and generic business will be invaluable in helping us navigate our business towards new growth opportunities.”
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%